EUR 13.71
(-0.65%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.97 Billion EUR | 16.81% |
2022 | 3.57 Billion EUR | 17.23% |
2021 | 3.13 Billion EUR | 19.11% |
2020 | 2.46 Billion EUR | -14.26% |
2019 | 2.7 Billion EUR | 29.39% |
2018 | 2.17 Billion EUR | 20.84% |
2017 | 1.74 Billion EUR | 2825.76% |
2016 | 1.78 Billion EUR | -109.3% |
2015 | 1.65 Billion EUR | 72.13% |
2014 | 1.42 Billion EUR | -67.78% |
2013 | 1.28 Billion EUR | 90.04% |
2012 | 2.06 Billion EUR | -69.69% |
2011 | 2.26 Billion EUR | -5.82% |
2010 | 2.43 Billion EUR | 8.83% |
2009 | 2.23 Billion EUR | 2.12% |
2008 | 2.16 Billion EUR | -12.37% |
2007 | 2.46 Billion EUR | 12.13% |
2006 | 2.15 Billion EUR | 35.89% |
2005 | 1.64 Billion EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 1.01 Billion EUR | 6.24% |
2024 Q1 | 925 Million EUR | 25.1% |
2023 FY | - EUR | 16.81% |
2023 Q2 | 1.06 Billion EUR | 3.59% |
2023 Q1 | 1.03 Billion EUR | 95.45% |
2023 Q4 | 780 Million EUR | -3.35% |
2023 Q3 | 807 Million EUR | -24.51% |
2022 Q3 | 930 Million EUR | 0.87% |
2022 Q4 | 528 Million EUR | -43.23% |
2022 FY | - EUR | 17.23% |
2022 Q2 | 922 Million EUR | -3.15% |
2022 Q1 | 952 Million EUR | 85.94% |
2021 Q2 | 668 Million EUR | -22.42% |
2021 FY | - EUR | 19.11% |
2021 Q1 | 861 Million EUR | 70.16% |
2021 Q4 | 512 Million EUR | -37.18% |
2021 Q3 | 815 Million EUR | 22.01% |
2020 Q1 | 687 Million EUR | 18.04% |
2020 Q3 | 704 Million EUR | 37.77% |
2020 FY | - EUR | -14.26% |
2020 Q4 | 506 Million EUR | -28.13% |
2020 Q2 | 511 Million EUR | -25.62% |
2019 Q1 | 844 Million EUR | 466.44% |
2019 Q2 | 699 Million EUR | -17.18% |
2019 Q3 | 682 Million EUR | -2.43% |
2019 Q4 | 582 Million EUR | -14.66% |
2019 FY | - EUR | 29.39% |
2018 Q2 | 525 Million EUR | -39.66% |
2018 Q4 | 149 Million EUR | -76.27% |
2018 Q3 | 628 Million EUR | 19.62% |
2018 FY | - EUR | 20.84% |
2018 Q1 | 870 Million EUR | 10775.0% |
2017 Q2 | 400 Million EUR | -42.61% |
2017 Q1 | 697 Million EUR | 209.78% |
2017 Q4 | 8 Million EUR | -98.37% |
2017 Q3 | 490 Million EUR | 22.5% |
2017 FY | - EUR | 2825.76% |
2016 Q1 | 747 Million EUR | 474.62% |
2016 FY | - EUR | -109.3% |
2016 Q4 | 225 Million EUR | -56.73% |
2016 Q3 | 520 Million EUR | 246.48% |
2016 Q2 | -355 Million EUR | -147.52% |
2015 Q3 | 457.37 Million EUR | 37.35% |
2015 FY | - EUR | 72.13% |
2015 Q2 | 333 Million EUR | -49.62% |
2015 Q1 | 661 Million EUR | 921.61% |
2015 Q4 | 130 Million EUR | -71.58% |
2014 FY | - EUR | -67.78% |
2014 Q1 | 418.5 Million EUR | -16.09% |
2014 Q3 | 410 Million EUR | -14.32% |
2014 Q2 | 478.5 Million EUR | 14.34% |
2014 Q4 | 64.7 Million EUR | -84.22% |
2013 Q4 | 498.72 Million EUR | 0.0% |
2013 FY | - EUR | 90.04% |
2013 Q2 | 520.27 Million EUR | 0.0% |
2013 Q1 | 520.27 Million EUR | -5.38% |
2013 Q3 | 498.72 Million EUR | -4.14% |
2012 FY | - EUR | -69.69% |
2012 Q4 | 549.88 Million EUR | 0.0% |
2012 Q3 | 549.88 Million EUR | 0.0% |
2011 FY | - EUR | -5.82% |
2010 FY | - EUR | 8.83% |
2009 FY | - EUR | 2.12% |
2008 FY | - EUR | -12.37% |
2007 FY | - EUR | 12.13% |
2006 FY | - EUR | 35.89% |
2005 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Bioera S.p.A. | -3.19 Million EUR | 124646.024% |
GPI S.p.A. | 67.95 Million EUR | -5753.788% |